|
|
 |
|
Viewing report
|
|
|
|
Boston Scientific Sells its Neurovascular Business to Stryker: A Move to Invest in Future Growth Opportunities - Deal Analysis From GlobalData
GlobalData, Nov 2010, Pages: 5
Boston Scientific Sells its Neurovascular Business to Stryker: A Move to Invest in Future Growth Opportunities - Deal Analysis From GlobalData
Summary
Our report, “Boston Scientific Sells its Neurovascular Business to Stryker: A Move to Invest in Future Growth Opportunities” provides key information and analysis on Stryker’s acquisition of Boston Scientific’s neurovascular business. The report provides information on global interventional neurology devices market revenues from 2009 to 2016 and epidemiology of brain aneurysms and brain stroke. The report also provides qualitative information on deal rationale.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
Scope
- Global interventional neurology devices market revenues from 2009 to 2016.
- Qualitative analysis on Stryker’s acquisition of Boston Scientific’s neurovascular business.
- Global epidemiology of brain aneurysms and brain stroke.
- Boston Scientific’s market share in interventional neurology devices market in 2009.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the interventional neurology devices market
- Design and develop your marketing and sales strategies
- Develop market expansion strategies
- Exploit M&A opportunities by identifying key areas of growth
- Make more informed business decisions from the insightful and in-depth analysis of the interventional neurology devices market
|
|
|
|
